Stock listing
LSE:0LC7 Syros Pharmaceuticals, Inc. Share Price
UK listing (LSE) of Syros Pharmaceuticals, Inc. · home listing OTC:SYRS
Follow Syros Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · LSE:0LC7
$0.0004 USD 0.0000 (0.0%)
Close on Oct 27, 2026
- Day range
- $0.0004 – $0.0004 USDOct 27, 2026
- Volume
- 422 sharesOct 27, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:SYRS · Home | $0.0004 USD | 0.0000 (0.0%) | 8,588 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | Close on Nov 2, 2026 |
| LSE:0LC7 | $0.0004 USD | 0.0000 (0.0%) | 422 | $0.0004 | $0.0004 | $0.0004 | $0.0004 | Close on Oct 27, 2026 |
- Ticker
- LSE:0LC7
- Asset type
- Stock
- Exchange
- LSE
- Currency
- USD
Calls
Replays
Syros Pharmaceuticals (OTC:SYRS) Q3 2024 Earnings Call
Thu, Oct 31, 2024 · 8:30 AM ET
Watch TranscriptSyros Pharmaceuticals (OTC:SYRS) Q2 2024 Earnings Call
Wed, Jul 31, 2024 · 8:30 AM ET
Watch TranscriptSyros Pharmaceuticals (OTC:SYRS) Q1 2024 Earnings Call
Tue, May 14, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Decks
JP Morgan Conference January 2024
Conference · 18 slides · Jan 8, 2024
Technical Presentation (December 2023)
Technical · 16 slides · Dec 6, 2023
Investor Presentation (May 2023)
Investor deck · 25 slides · May 25, 2023
Investor Presentation (January 2023)
Investor deck · 25 slides · Jan 9, 2023
Syros Pharmaceuticals, Inc. on 6ix
- News releases
- 2 in all · newest Jul 16, 2025 · oldest 2025
- Calls
- 15 calls with a replay · 15 with a transcript · latest Oct 31, 2024
- Decks
- 18 decks · latest Jan 8, 2024
Where Syros Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| OTC:SYRS · Home listing | OTC | United States | USD |
| LSE:0LC7 · This page | LSE | United Kingdom | USD |
| LS Exchange:A3DT8V | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3DT8V | Lang & Schwarz | Germany | EUR |
Log in to ask 6ix AI your own questions about Syros Pharmaceuticals, Inc.